BioSight
Companies
Organon & Co. logo

OGN

NYSEJERSEY CITY, NJ
Organon & Co.

Organon & Co. is a global pharmaceutical company with a portfolio of over 70 products focused on women's health—including contraceptives like Nexplanon and NuvaRing, and fertility treatments like Follistim AQ—as well as general medicines including biosimilars in immunology and oncology. The company sells established, marketed products through wholesalers, retailers, hospitals, and managed care providers across over 140 countries and operates six manufacturing facilities globally. Organon is primarily a commercial-stage company focused on maximizing revenue from its existing product portfolio rather than developing new drugs through clinical trials.

Price history not yet available for OGN.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar